BCAX Market Cap & Key Metrics
Bicara Therapeutics Inc. Common Stock
$17.62
+$0.28(+1.61%)
36
Overall
60
Value
27
Tech
21
Quality
Market Cap
$1.15B
Volume
662.06K
52W Range
$13.70 - $30.99
Target Price
$34.62
BCAX market cap is $1.15B. This page lists Bicara Therapeutics Inc. Common Stock's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
BCAX Key Metrics
- Market cap
- $1.15B
- EPS estimate, current year
- $-3.49
- EPS growth, 3-year
- +69.43%
- Value score
- 60
- Quality score
- 21
- Technical score
- 27
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| EBITDA | -$137.63M | -$67.75M | -$51.96M | -$37.72M |
| EPS | $-2.52 | $-4.05 | $-89.61 | $-88.20 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $17.62 | +1.6% | 662.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW